23andMe to launch study exploring role of genetics in depression, bipolar disorders

Personal genetics company 23andMe will be teaming up with the Milken Institute, a think tank, and pharmaceutical company Lundbeck to drive enrollment for a genetic study designed to grasp the underlying biology of major depressive and bipolar disorders.  
Source: mobihealthnews - Category: Information Technology Source Type: news